15.01.2013 Views

EMBO Fellows Meeting 2012

EMBO Fellows Meeting 2012

EMBO Fellows Meeting 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Vanessa Luis<br />

<strong>EMBO</strong> <strong>Fellows</strong> <strong>Meeting</strong> <strong>2012</strong><br />

Lipid metabolism and malaria liver infection<br />

Abstract<br />

The liver stage constitutes the first obligatory step of Plasmodium infection in the vertebrate host, being<br />

hepatocytes the only cell type that can efficiently support complete growth and development of the<br />

Plasmodium exoerythrocytic form (EEF). This unique cellular environment allows the replication of single<br />

sporozoites into thousands of new merozoites over a period, for rodent infections, as short as two days.<br />

This extensive proliferation rate necessarily requires the availability of sufficient lipids for the synthesis of large<br />

amounts of additional membranes. Interestingly, while Plasmodium lacks some key enzymes for lipid<br />

synthesis, hepatocytes are specialized in the biosynthesis of lipids and the liver is known to play a central role<br />

in lipid homeostasis. It is therefore tempting to hypothesize that hepatocytes are favoured by Plasmodium<br />

sporozoites because of their inherent ability to mobilize lipids. In fact, ongoing work in the lab shows that by<br />

engaging the host cell’s resources to its own benefit (thereby fulfilling its molecular needs for multiplication),<br />

Plasmodium development inside the hepatocyte leads to alterations in host cell lipid metabolism. On the other<br />

hand, although only recently appreciated, there is an overwhelming amount of evidence that the metabolic<br />

systems, namely lipid metabolism, are integrated with pathogen-sensing and immune responses. Here, we<br />

observe that the modulation of host lipid metabolism through the administration of a rich-fat diet almost<br />

completely abrogates Plasmodium liver infection. We now propose to explain the mechanism behind the<br />

observed effect of the administration of exogenous lipids on infection by interrogating both the activation of<br />

the immune system and the metabolic alterations.<br />

Instituto de Medicina Molecular, Lisboa, Portugal<br />

14-17 June <strong>2012</strong>, Heidelberg, Germany

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!